Inturai Ventures Secures $940,999 in Initial Private Placement

The offering, which is slated to continue in additional tranches over the coming weeks, aims for a total target of $1,275,000. Each unit provided to investors consists of one common share and one share purchase warrant. These warrants allow holders to acquire additional common shares at $0.25 within a twenty-four-month window, provided the company meets specific accelerated expiry conditions tied to the stock reaching a $0.35 threshold for five consecutive trading days.

Inturai utilized the listed issuer financing exemption for this sale, meaning the units are immediately free-trading in most Canadian provinces. To facilitate the introduction of subscribers, the company paid $9,900 and issued 66,000 finder warrants to arm's-length parties. These specific warrants carry a two-year term at the same $0.25 exercise price but remain subject to resale restrictions until December 29, 2026. The firm, led by CEO Ed Clarke, focuses on AI applications across healthcare, military, and industrial environments.